Evidence map›Paper›PMID 29074451›Full record

ArticleGastroenterology2018

Mitochondrial Dysfunction, Through Impaired Autophagy, Leads to Endoplasmic Reticulum Stress, Deregulated Lipid Metabolism, and Pancreatitis in Animal Models.

Gyorgy Biczo, Eszter T Vegh, Natalia Shalbueva, Olga A Mareninova, Jason Elperin, Ethan Lotshaw, Sophie Gretler, Aurelia Lugea, Sudarshan R Malla, David Dawson and 10 more

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04761523 (The Effect of Dietary Fat Content on the Recurrence of Pancreatitis), which is not on this map. Cited by 214 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
214citing papers in PubMed, 2 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04761523 narecruitingnot on this mapstarted 2022, after this paper: background citation

The Effect of Dietary Fat Content on the Recurrence of Pancreatitis (EFFORT): Protocol of a Multicentre Randomized Controlled Trial

TypeinterventionalSponsorUniversity of PecsRan2022 to 2026Enrolled384ConditionsAcute PancreatitisArmsDietary intervention: reduced fat diet, Dietary intervention: standard healthy diet
3 · Its place in the literature

Who cites it

214 citing papers in PubMed, 2 syntheses or guidelines pooled it, 411 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Genetic and pharmacologic modulations elucidate NRF2 protective role in acute pancreatitis.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Personalizing treatment of pancreatitis-associated chronic pain: the need for an integrated omics approach.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Acute pancreatitis: mechanisms and therapeutic approaches.Signal transduction and targeted therapy · 2026
    Review
  19. Article
  20. Review

154 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Gyorgy BiczoDavid Geffen School of Medicine, University of California at Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California; First Department of Medicine, University of Szeged, Szeged, Hungary; Department of Pathophysiology, University of Szeged, Szeged, Hungary.
Eszter T VeghDavid Geffen School of Medicine, University of California at Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California; First Department of Medicine, University of Szeged, Szeged, Hungary; Department of Pathophysiology, University of Szeged, Szeged, Hungary.
Natalia ShalbuevaDavid Geffen School of Medicine, University of California at Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California.
Olga A MareninovaDavid Geffen School of Medicine, University of California at Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California.
Jason ElperinDavid Geffen School of Medicine, University of California at Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California.
Ethan LotshawDavid Geffen School of Medicine, University of California at Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California.
Sophie GretlerDavid Geffen School of Medicine, University of California at Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California.
Aurelia LugeaCedars-Sinai Medical Center, Los Angeles, California.
Sudarshan R MallaDavid Geffen School of Medicine, University of California at Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California.
David DawsonDavid Geffen School of Medicine, University of California at Los Angeles, California.
Piotr RuchalaDavid Geffen School of Medicine, University of California at Los Angeles, California.
Julian WhiteleggeDavid Geffen School of Medicine, University of California at Los Angeles, California.
Samuel W FrenchHarbor-UCLA Medical Center, Torrance, California.
Li WenDepartment of Pediatric GI, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Sohail Z HusainDepartment of Pediatric GI, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Fred S GorelickYale University, New Haven, Connecticut.
Peter HegyiInstitute for Translational Medicine and First Department of Medicine, University of Pecs, Pecs, Hungary; Translational Gastroenterology Research Group, University of Szeged, Szeged, Hungary.
Zoltan RakonczayFirst Department of Medicine, University of Szeged, Szeged, Hungary; Department of Pathophysiology, University of Szeged, Szeged, Hungary.
Ilya GukovskyDavid Geffen School of Medicine, University of California at Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California.
Anna S GukovskayaDavid Geffen School of Medicine, University of California at Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California. Electronic address: agukovsk@ucla.edu.
University of California, Los Angeles · USUniversity of Pittsburgh · USUniversity of Szeged · HUCedars-Sinai Medical Center · USHarbor–UCLA Medical Center · USYale University · US

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Vector and Human Acinar CoreP01DK098108 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GUKOVSKY, ILYA · 2014 to 2018
$8.1M
EXOCRINE PANCREATIC ZYMOGEN ACTIVATIONR01DK054021 · NIDDK · YALE UNIVERSITY · PI GORELICK, FRED SANFORD · 1998 to 2018
$3.6M
HDACs in pancreatic recovery after injuryR01DK103002 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUSAIN, SOHAIL Z · 2014 to 2017
$1.6M
Lysosomal Damage, Impaired Autophagy, and Alcoholic PancreatitisR01AA019730 · NIAAA · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI GUKOVSKY, ILYA, MARENINOVA, OLGA A · 2011 to 2015
$1.4M
Regulation of pancreatitis severityI01BX003250 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI Fred Sanford Gorelick · 2016 to 2026
–
BLRD VA I01 BX003250BLRD VA I01 BX004306NIAAA NIH HHS R01 AA019730NIDDK NIH HHS P01 DK098108NIDDK NIH HHS P30 DK041301NIDDK NIH HHS R01 DK054021NIDDK NIH HHS R01 DK103002
6 · The paper itself

Abstract

BACKGROUND &

aimsLittle is known about the signaling pathways that initiate and promote acute pancreatitis (AP). The pathogenesis of AP has been associated with abnormal increases in cytosolic Ca

methodsPancreatitis was induced in C57BL/6J mice (control) and mice deficient in peptidylprolyl isomerase D (cyclophilin D, encoded by Ppid) by administration of L-arginine (also in rats), caerulein, bile acid, or an AP-inducing diet. Parameters of pancreatitis, mitochondrial function, autophagy, ER stress, and lipid metabolism were measured in pancreatic tissue, acinar cells, and isolated mitochondria. Some mice with AP were given trehalose to enhance autophagic efficiency. Human pancreatitis tissues were analyzed by immunofluorescence.

resultsMitochondrial dysfunction in pancreas of mice with AP was induced by either mitochondrial Ca

conclusionsIn different animal models, we find a central role for mitochondrial dysfunction, and for impaired autophagy as its principal downstream effector, in development of AP. In particular, the pathway involving enhanced interaction of cyclophilin D with ATP synthase mediates L-arginine-induced pancreatitis, a model of severe AP the pathogenesis of which has remained unknown. Strategies to restore mitochondrial and/or autophagic function might be developed for treatment of AP.

Indexed as

AutophagyEndoplasmic Reticulum StressLipid MetabolismAcute DiseaseAnimalsArginineBile Acids and SaltsCalcium SignalingCeruletideCholine DeficiencyCyclophilinsDisease Models, AnimalEthionineGenetic Predisposition to DiseaseHumansMembrane Potential, MitochondrialArginineBile Acids and SaltsCeruletideCyclophilinsEthionineMitochondrial Proton-Translocating ATPasesPeptidyl-Prolyl Isomerase FPPIF protein, mouseTrehaloseAcinar CellInflammatory ResponseLamellar BodiesPancreas

Identifiers

PMID29074451
PMCPMC6369139
OpenAlexW2766966618

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.